Novus Therapeutics to Participate in Two Upcoming Investor Conferences
Novus Therapeutics, Inc. (Novus) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT).
Read More
Category: US Stocks
Zynerba Pharmaceuticals Announces Poster Presentations at the 22nd Society for the Study of Behavioural Phenotypes (SSBP) Symposium
The meeting is being held at Aston University in Birmingham, UK on September 4th through 6th, 2019.
Read More
WeedMD Reports Second Quarter 2019 Financial Results
Net revenues increase to $8 million representing a quarter-over-quarter increase of 139%.
Read More
Green Thumb Industries (GTI) Triples Revenue to $44.7 Million and Reports $5.0 Million in Adjusted Operating EBITDA in Second Quarter 2019
Second quarter 2019 revenue increased 228% year-over-year to $44.7 million.
Read More
KALY- Kali-Extracts Announces New Analyst Report Speculating $0.05 PPS Following Recent Biopharmaceutical Cannabis Extract Updates
The report speculates a potential KALY price per share of $0.05.
Read MoreGET LISTED
